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Abstract
Background: Vaccination has been one of the most successful public health interventions to date, and the U.S.
FDA/CDC Vaccine Adverse Event Reporting System (VAERS) currently contains more than 500,000 reports for
post-vaccination adverse events that occur after the administration of vaccines licensed in the United States. The
VAERS dataset is huge, contains very large dimension nominal variables, and is complex due to multiple listing of
vaccines and adverse symptoms in a single report. So far there has not been any statistical analysis conducted in
attempting to identify the cross-board patterns on how all reported adverse symptoms are related to the vaccines.
Methods: For studies of the relationship between vaccines and reported adverse events, we consider a partial VAERS
dataset which includes all reports filed over a period of 24 years between 1990-2013. We propose a neighboring
method to process this dataset for dealing with the complications caused by multiple listing of vaccines and adverse
symptoms in a single report. Then, the combined approaches based on our neighboring method and novel utilization
of data visualization techniques are employed to analyze the large dimension dataset for characterization of the
cross-board patterns of the relations between all reported vaccines and events.
Results: The results of our analysis indicate that those events or symptoms with overall high occurrence frequencies
are positively correlated, and those most frequently occurred adverse symptoms are mostly uncorrelated or negatively
correlated under different bacteria vaccines, but they are in many cases positively correlated under different virus
vaccines, especially under flu vaccines. No particular patterns are shown under live vs. inactive vaccines.
Conclusions: This article identifies certain cross-board patterns of the relationship between the vaccines and the
reported adverse events or symptoms. This helps for better understanding the VAERS data, and provides a useful
starting point for the development of statistical models and procedures to further analyze the VAERS data.
Keywords: Bacteria vaccine, Correlation coefficient matrix, Data visualization, Inactivated vaccine, Live vaccine,
Neighboring method, Virus vaccine
Background
Vaccination has been one of the most successful public
health interventions to date. However, the use of vac-
cine sometimes comes with possible adverse events.
Since 1990, the U.S. FDA/CDC Vaccine Adverse Event
Reporting System (https://vaers.hhs.gov/data/datasets.
html) (VAERS) has received 530,716 case reports by the
end of 2016 for post-vaccination events that occur after
the administration of vaccines licensed in the United
States. The primary objectives of VAERS are to detect
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new, unusual or rare vaccine adverse events or symptoms;
monitor increase in known adverse events; identify poten-
tial patient risk factors for particular types of adverse
events; assess the safety of newly licensed vaccines; etc.
Each VAERS report includes the following information
of an individual: patient ID, place of vaccination, age, gen-
der, vaccines administrated, adverse events or symptoms
observed, time between vaccination and adverse event
onset, etc. The VAERS data at FDA site are not ready for
statistical analysis without being processed, because each
report lists adverse events or symptoms in the form of
non-regulated words or phrases, and often contains mul-
tiple listing of symptoms along with multiple listing of
vaccines. Taking into account the possible multiple listing
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of vaccines and adverse events or symptoms in one report,
a well processed dataset file based on current 530,716 case
reports during 1990-2016 is estimated to have 2,000,000
- 3,000,000 rows. Thus, this is a big and complicated data
set.
Challenges: In addition to the large data size issue, as
the key components for our research interests the vaccine
variable V and symptom variable Z in VAERS data are
nominal variables, and the already very large dimension of
symptom variable Z (i.e., the total number of different cat-
egories) can still increase as more reports are being filed
each year. In statistical literature, we have few tools for
such kind of data analysis involving nominal categorical
variable with unlimited dimension. Another big compli-
cation of the VAERS data is due to above mentioned
multiple listing of vaccines administrated and multiple
listing of adverse symptoms in one single VAERS report.
For instance, one report may list vaccines A and B and
list adverse symptoms C, D and E. In such a case, we
do not exactly know which symptom was triggered by
which vaccine. Unfortunately, such huge complication in
VAERS data will continue until one vaccination per time
is enforced in U.S. Thus, this posts great challenges for the
analysis of vaccine data.
Dr. He of this project team was the primary developer
of the vaccine ontology. Recently, he and Dr. Zhang (co-
author of this article) along with other collaborators have
conducted some network-based studies on the VAERS
data to summarize and analyze the vaccine-adverse event
association [1–3], and have done some ontology-based
comparative analyses on the adverse event associated with
killed and live influenza vaccines [4]. But these works are
not the statistical analysis in the usual sense.
It is well-known that before a particular vaccine was
marketed, clinical trials had already identified some
adverse symptoms or events associated with such vaccine.
However, this is not equivalent to the cross-board pat-
terns of the relations between vaccines and adverse events
or symptoms. With huge VAERS data accumulated at this
point, the analysis of such cross-board patterns becomes
possible, but so far there has not been any statistical
analysis conducted in attempting to identify the cross-
board patterns on how all reported adverse symptoms are
related to the vaccines. Characterizing such cross-board
patterns is of importance on its own for better under-
standing the VAERS data, and would provide insights for
developing statistical models and procedures for further
analysis of VAERS data. In particular, the characteriza-
tion of cross-board patterns is in fact a method of using
all available data together to deal with the big complica-
tion problem in VAERS data caused by aforementioned
multiple listing of vaccines and adverse symptoms in a sin-
gle report; that is one single report with multiple listing
makes it impossible for us to know exactly which symptom
was triggered by which vaccine, but putting all reports
with related information together can lead us to identify
cross-board patterns on the relationship between vaccines
and adverse symptoms.
In this article, a partial VAERS dataset is considered
for characterizing the cross-board patterns of the rela-
tionship between all reported vaccines and all reported
adverse symptoms or events. We propose a neighboring
method to process the raw VAERS data, and we analyze
this processed large dimension dataset via novel utiliza-





As mentioned above, the original VAERS data at FDA site
are not ready for statistical analysis without being pro-
cessed. Here, for the study of causal relationship between
all reported vaccines and all reported events or symp-
toms, we consider a partial dataset of VAERS data which
was based on all 407,453 reports filed over a period of
24 years between 1990–2013. This partial dataset is pro-
cessed using our proposed neighboring method into the
following form of n = 277, 698 vectors:
V = (Y,V ,Z,W ), (1)
where Y represents year; V represents the vaccines
with a total of 72 different types; Z represents the
symptoms, such as abdominal pain, anxiety, autism,
blindness, coma, depression, eye disorder, fatigue,
headache, inflammation, swelling, vomiting, etc., with
a total of 7368 different symptoms; and W repre-
sents the total number of occurrences of symptom
Z after vaccine V was administrated during year Y.
For instance, vector (1991, DTP, Pyrexia, 2107) means
that during year 1991, the occurrence of symptom
Z=[Pyrexia] after vaccine V=[DTP]’s being admin-
istrated was listed in a total of W=2107 reports;
vector (2003, DTAP, Injection Site Erythema, 1797)
means that during year 2003, the occurrence of symptom
Z=[Injection Site Erythema] after vaccine V=[DTAP]’s
being administrated was listed in W=1797 reports; and
vector (2009, FLU(H1N1), Rash, 547) means that during
year 2009, the occurrence of symptom Z=[Rash] after
vaccine V=[FLU(H1N1)]’s being administrated was listed
in W=547 reports. In this paper, our processed dataset
only includes those vectors with positive frequency
variableW.
NeighboringMethod
For the case of a report with multiple listing of vaccines
and events or symptoms as aforementioned, it is pro-
cessed as follows. If a report lists vaccines A and B and lists
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symptoms or events C, D and E, each of symptoms C, D
and E is counted once for each of vaccines A and B, respec-
tively, for frequency variableW in Eq. (1). The description
and rationale of our proposed neighboring method are:
(i) From this one single report, we do not know whether
symptom C was triggered by vaccine A or vaccine B
or both; the same goes with symptoms D and E;
(ii) Because of (i), we count the occurrence of symptom
C under vaccine A once, adding 1 into the
corresponding frequency variable W in Eq. (1); also
count the occurrence of symptom C under vaccine B
once; and do the same for symptoms D and E for the
same reasons;
(iii) The resulting processed data in the form of Eq. (1) as
a whole allow us to use all reports including, say,
symptom C and vaccine A, to study the cross-board
patterns of the relationship between all reported
vaccines and all reported adverse symptoms, which
contain symptom C and vaccine A as a pair. This is
Table 1 List of Top 100 Adverse Symptoms
i Zi FQi i Zi FQi i Zi FQi
1 Pyrexia 138934 35 Injection site mass 15186 69 Blister 6100
2 Injection site erythema 82620 36 Cough 14802 70 Chest pain 6083
3 Rash 56780 37 Fatigue 14007 71 Loss of consciousness 6025
4 Injection site swelling 48210 38 Cellulitis 13798 72 Rash macular 5905
5 Erythema 48062 39 Malaise 13365 73 Insomnia 5865
6 Injection site pain 47536 40 Injection site reaction 12359 74 Musculoskeletal stiffness 5765
7 Pain 41738 41 Tremor 12234 75 Pharyngitis 5698
8 Urticaria 37259 42 Syncope 12169 76 Laboratory test abnormal 5631
9 Vomiting 37137 43 Somnolence 11731 77 Decreased appetite 5570
10 Injection site oedema 35952 44 Feeling hot 11700 78 Herpes zoster 5523
11 Pruritus 34937 45 Oedema 11584 79 Back pain 5436
12 Headache 31439 46 Paraesthesia 11329 80 Face oedema 5370
13 Injection site warmth 30571 47 Rash maculo-papular 11287 81 Rash generalised 5323
14 Injection site hypersensitive 27569 48 Skin warm 10211 82 Otitis media 5314
15 Dizziness 24429 49 Hypotonia 9627 83 Apnoea 5274
16 Crying 24345 50 Rash erythematous 9008 84 Neck pain 5254
17 Agitation 24058 51 Body temperature increase 8889 85 Gait disturbance 5105
18 Convulsion 23891 52 Hyperhidrosis 8345 86 Gaze palsy 5092
19 Nausea 23694 53 Lymphadenopathy 8329 87 Condition aggravated 4884
20 Oedema peripheral 23154 54 Hypoaesthesia 8326 88 Immed. post-injection reaction 4850
21 Diarrhoea 19343 55 Tenderness 8261 89 White bloodcell count increase 4775
22 Injection site induration 18762 56 Anorexia 8151 90 Wheezing 4752
23 Dyspnoea 18074 57 Hypersensitivity 8148 91 Rash vesicular 4740
24 Screaming 17991 58 Injection site pruitus 7500 92 Muscle twitching 4684
25 Myalgia 17983 59 Hypokinesia 7494 93 Rhinorrhoea 4648
26 Chills 17244 60 Dermatitis bullous 7310 94 Muscular weakness 4515
27 Pain in extremity 16667 61 Febrile convulsion 7226 95 Rhinitis 4509
28 Swelling 16439 62 Abdominal pain 7081 96 Dyskinesia 4135
29 Infection 16313 63 Injection site rash 7076 97 Skin ulcer 4016
30 Vasodilatation 16254 64 Lethargy 7025 98 Hypertonia 4003
31 Pallor 16001 65 Cyanosis 6953 99 Rash pruritic 3988
32 Asthenia 15661 66 Stupor 6798 100 Skin discolouration 3835
33 Irritability 15476 67 Rash papular 6415
34 Arthralgia 15208 68 Viral infection 6295
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the idea of using all neighboring information to study
the relation of a particular pair.
Additional Notes
Some of the VAERS reports considered in our studies here
contain errors or incomplete information. For instance,
some reports list the vaccine as “unknown”, thus these
reports are excluded in some parts of our data analysis.
Also, among the reported events or symptoms, some of
them are adverse, while some are not considered to be
adverse, such as drug ineffective, inappropriate schedule
of drug administration, unevaluable event, wrong drug
administration, full blood count, full blood count nor-
mal, etc. In the parts of our analysis on the relationship
between the vaccines and the adverse events or symptoms,
we exclude those vectors in Eq. (1) if Z is a non-adverse
event or symptom.
Top 100 Adverse Symptoms
Due to the large size of the dataset being considered in this
research and due to our limited computing power, parts
of our analysis here focus on the cross-board patterns
of how those most frequently occurred adverse symp-
toms or events are related to the vaccines, because it
would take several weeks to complete just one explorative
data visualization plot for all 7368 symptoms due to its
large dimension. Specifically, excluding those non-adverse
events or symptoms aforementioned, the top 100 adverse
symptoms or events with highest overall occurrence fre-
quencies in the processed VAERS dataset (1) are identified
and listed in Table 1, where Z1 is the adverse symptom
with the highest occurrence frequency in the dataset, Z2
is the adverse symptom with the 2nd highest occurrence
frequency in the dataset, and so forth; and FQi is the total
occurence frequency for symptom Zi. Hereafter in this
article, these are referred as the top 100 adverse symptoms.
We note that among top 107 events or symptoms with
highest overall occurrence frequencies, seven are non-
adverse, thus Table 1 does not include these 7 non-adverse
events.
Data visualization and statistical analysis
In addition to the large size issue, the analysis of VAERS
data deals with nominal variables such as vaccines and
events or symptoms; in particular, the symptom is a nom-
inal variable of very large dimension. Here, we use data
visualization methods in our studies.
For an initial data visualization, we consider all differ-
ent n = 7368 events or symptoms reported in processed
VAERS dataset (1) and arrange them according to the
alphabetical order: E1,E2, · · · ,En. We denote all reported
72 vaccines according to the following order:
V1,V2, · · · ,V72 (2)
where V1, · · · ,V24 are alphabetically ordered 24 bacte-
ria vaccines, V25, · · · ,V62 are alphabetically ordered 38
virus vaccines, V63, · · · ,V71 are alphabetically ordered 9
bacteria/virus combined vaccines, and V72 represents the
vaccine listed as unknown. For each vaccine Vk , we obtain
the frequency vector Xk = (Xk1,Xk2, · · · ,Xkn), where
n = 7, 368 and Xki is the total number of times that event
Ei was reported for vaccine Vk . Based on these 72 vectors























i, j = 1, 2, · · · , 7368
(3)
where X̄i is the sample mean of X1,i, · · · ,X72,i, and ρ̂ij is
the sample correlation coefficient of symptoms Ei and Ej.
This matrix is displayed in Fig. 1a, where red dots rep-
resent for those ρ̂ij > 0.01, white dots for |ρ̂ij| ≤ 0.01,
and blue dots for ρ̂ij < −0.01. Throughout this article,
all matrices are displayed as the rotated version of the
conventional matrix, i.e., with the bottom row of the con-
ventional matrix as the top row here. Obviously, Fig. 1a
shows no informative patterns about the dataset.
Fig. 1 Correlation matrix of all reported events
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Next, we denote all reported symptoms or events in
VAERS data (1) by: E1,E2, · · · ,En, where E1 is the symp-
tom or event with the highest occurrence frequency in the
dataset, E2 is the symptom or event with the 2nd high-
est occurrence frequency in the dataset, and so forth. For
each vaccine Vk in (2), we obtain the frequency vector
Y k = (Yk1,Yk2, · · · ,Ykn), where Yki is the total number
of times that event Ei was reported for vaccine Vk . Based
on such 72 vectors Y k , we compute the rotated matrix of
sample correlation coefficients ρ̂Yij using the formula in (3)
for Yki’s, where ρ̂Yij is the sample correlation coefficient of
symptoms Ei and Ej. This matrix is displayed in Fig. 1b,
where the colored dots have the same meaning for ρ̂Yij as
for those in Fig. 1a. In addition, Fig. 1c displays the matrix
of Fig. 1b with 20 different colors to illustrate the values of
the sample correlation coefficients ρ̂Yij , where green color
corresponds to values of ρ̂Yij around 0, color from green to
red corresponds to ρ̂Yij > 0, and color from green to blue
corresponds to ρ̂Yij < 0. Interestingly, such a method of
data visualization clearly indicates cross-board patterns.
For the study of the cross-board patterns on the rela-
tionship between the vaccines and the adverse events
or symptoms, we consider the top 100 adverse symp-
toms Z1, · · · ,Z100 listed in Table 1, and consider the
vaccines V1, · · · ,V71 listed in (2); that is in our anal-
ysis hereafter we exclude those vectors in processed
VAERS dataset (1) that list the vaccine as “unknown”.
For each year, we obtain frequency vector Fk =
(Fk,1,1, · · · , Fk,1,100, Fk,2,1, · · · , Fk,2,100, · · · Fk,71,100), where
k = 1, · · · , 24 represent 24 years between 1990–2013;
and Fkij is the total number of times that symptom Zj was
reported for vaccine Vi during year k. Based on these 24
vectors Fk , we compute the rotated 7100 × 7100 matrix
of sample correlation coefficients ρ̂ij,lq using the formula
Fig. 2 Correlation matrix of top 100 adverse symptoms under vaccines
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in (3) for Fkij’s, where ρ̂ij,lq is the sample correlation coef-
ficient of symptom Zj under vaccine Vi and symptom Zq
under vaccine Vl, thus ρ̂ij,iq is the sample correlation coef-
ficient of symptoms Zj and Zq under vaccine Vi. This
matrix is displayed in Fig. 2, where the colored dots have
the same meaning for ρ̂ij,lq as for those in Fig. 1c.
As indicated by solid lines, the matrix in Fig. 2 con-
sists of 712 = 5041 block matrices Mij, each of which is
of dimension 100 × 100 and is the matrix of sample cor-
relation coefficients of top 100 adverse symptoms under
vaccines Vi and Vj. For i = j, the block matrices Mij and
Mji satisfy Mij = Mji, while Mii is the matrix of sam-
ple correlation coefficients of top 100 adverse symptoms
under vaccineVi and is a blockmatrix located on the diag-
onal line of the matrix in the direction from bottom left to
top right.
Due to the order of vaccines Vi’s in (2), the bold dashed
lines separate the matrix of Fig. 2 into 9 big block matri-
ces, among which the square block matrix in the bottom
left, displayed separately in Fig. 3, is the matrix of sam-
ple correlation coefficients of top 100 adverse symptoms
under all 24 different bacteria vaccines; and the square
blockmatrix in themiddle, displayed separately in Fig. 5, is
the thematrix of sample correlation coefficients of top 100
adverse symptoms under all 38 different virus vaccines.
In Fig. 4, the top are block matrices M16,22 and M22,16
in Fig. 3, and the bottom are block matrices M16,21 and
M21,16 in Fig. 3. Due to better picture resolution reason,
these blockmatrices clearly show that equationMij = Mji
holds. The two block matrices on the top of Fig. 4 are
among those mostly green-blue colored block matrices in
Fig. 3, while the two block matrices on the bottom are the
Fig. 3 Correlation matrix under bacteria vaccines
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Fig. 4 Four Block Matrices of Fig. 3
very few non-diagonal block matrices in Fig. 3 that are
mostly red colored.
Figure 6 contains the block matrices Mij of Fig. 5 for
i, j = 3, 4, 5, 6, which are the correlation matrices for the
top 100 adverse symptoms under 4 different flu vaccines:
FLU, FLU(H1N1), FLUN and FLUN(H1N1).
For the study of the relations between vaccine-adverse
events and attributes of vaccines, such as live attenu-
ated vaccine vs. killed inactivated vaccine, Fig. 7 displays
the matrix of sample correlation coefficients of top 100
adverse symptoms under all 23 different live vaccines
in processed VAERS dataset (1), while Fig. 8 displays
the matrix of sample correlation coefficients of top 100
adverse symptoms under all 47 different inactive vaccines.
Results
Figure 1b shows that over all reported vaccines, those
reported events or symptoms (adverse or non-adverse)
with overall high occurrence frequencies are positively
correlated, while those with low occurrence frequencies
are negatively correlated. In comparison, the blue area of
Fig. 1b mostly shows green color in Fig. 1c, which, by
color design, indicates that the low-occurrence events or
symptoms are mostly uncorrelated.
Figure 3 shows that the top 100 adverse symptoms listed
in Table 1 are mostly uncorrelated or negatively correlated
under different bacteria vaccines. Also, the big rectangular
blockmatrix in the bottommiddle of Fig. 2 outlined by the
bold dashed lines are mostly green-blue colored, except
the row block #16 (bacteria vaccine MNQ), which indi-
cates that the top 100 adverse symptoms under bacteria
vaccines are mostly uncorrelated or negatively correlated
with the top 100 adverse symptoms under virus vaccines.
Figures 5 and 6 show that the top 100 adverse symptoms
are in many cases positively correlated under different
virus vaccines, especially under flu vaccines. In partic-
ular, Fig. 6 shows that the top 100 adverse symptoms
are strongly positively correlated under vaccines FLU and
FLUN, and they are even more strongly positively corre-
lated under vaccines FLU(H1N1) and FLUN(H1N1).
Figures 7 and 8 show that under different live or inactive
vaccines, the top 100 adverse symptoms are in some cases
positively correlated and in some cases negatively corre-
lated, because in both figures many mostly red or mostly
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Fig. 5 Correlation matrix under virus vaccines
blue non-diagonal blockmatrices are scattered all over the
places.
Summary
The results of our analysis indicate: (a) Over all
reported vaccines, those events or symptoms (adverse
or non-adverse) with overall high occurrence frequen-
cies are positively correlated, while those with low
occurrence frequencies are uncorrelated; (b) Those
most frequently occurred adverse symptoms or events
are mostly uncorrelated or negatively correlated under
different bacteria vaccines, but they are in many
cases positively correlated under different virus vac-
cines, especially under flu vaccines; (c) Under differ-
ent live or inactive vaccines, those most frequently
occurred adverse symptoms or events are in some
cases positively correlated and in some cases negatively
correlated.
Discussion
The FDA VAERS database provides useful information
for the analysis of the relations between the vaccines and
the adverse events or symptoms. However, the dataset is
huge, includes reports with multiple listing of vaccines
and adverse symptoms in a single report, and contains
reports with errors or incomplete information. Using our
proposed neighboring method for processing the raw
VAERS data coupled with novel and proper utilization of
data visualization techniques (arbitrary use of data visu-
alization obviously does not work, eg., Fig. 1a), here we
conclusively reveal some interesting cross-board patterns
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Fig. 6 Block matrices of Fig. 5 under Flu vaccines
for those most frequently occurred adverse symptoms or
events under bacteria vaccines vs virus vaccines as well
as under live vaccines vs inactive vaccines. Our find-
ings here suggest some insights and the direction of
further studies on certain vaccines and related adverse
symptoms.
For instance, our finding of the low-occurrence events
or symptoms’ being mostly uncorrelated may be inter-
preted as that the rarely occurred events or symptoms are
mainly vaccine-specific, they generally are not associated
among one another, thus are not onset as a cluster. Also,
although Fig. 3 shows that the top 100 adverse symptoms
are mostly uncorrelated or negatively correlated under
different bacteria vaccines, the block matrices M16,21 and
M21,16 in Fig. 4 show that they are, as an isolated case,
very much positively correlated under bacteria vaccines
MNQ (#16, Meningococcal Vaccine Menactra) and PPV
(#21, Pneumococcal Polysaccharide Vaccine). Moreover,
although as shown by the big rectangular block matrix in
the bottom middle of Fig. 2, the top 100 adverse symp-
toms under bacteria vaccines are mostly uncorrelated or
negatively correlated with the top 100 adverse symptoms
under virus vaccines, the row block #16 (bacteria vaccine
MNQ) of this big rectangular block matrix indicates that
the top 100 adverse symptoms under bacteria vaccine
MNQ are positively correlated with those under many
virus vaccines.
Interestingly, as shown in Fig. 6, the top 100 adverse
symptoms are strongly positively correlated under
FLU (inactivated flu vaccine, virus vaccine) and FLUN
Ren et al. BMCMedical Informatics and DecisionMaking          (2019) 19:101 Page 10 of 12
Fig. 7 Correlation matrix under live vaccines
(live flu vaccine), but not as strong as those under
FLU(H1N1) and FLUN(H1N1). Such difference is
likely due to the fact that FLU and FLUN are typi-
cally prepared using three flu viruses: an influenza
A (H1N1) virus, an influenza A (H3N2) virus, and
an influenza B virus. However, FLU(H1N1) and
FLUN(H1N1) are prepared with only one influenza A
(H1N1) virus.
In addition to the differences between live vs inactivated
vaccines and between bacterial and viral vaccine types
which have been considered in this article, other factors
such as whole organism vs subunit vaccines, etc., may also
affect the outcome of adverse events or symptoms. Fur-
ther investigation and data analysis on VAERS data are
needed.
Conclusions
In this article, we identify certain cross-board patterns of
the relationship between the vaccines and the reported
events or symptoms via the combined approaches based
on our proposed neighboring method and novel utiliza-
tion of data visualization techniques. This is useful for
better understanding the VAERS data, and shows that the
data visualization method, if used properly, can serve as a
helpful tool for big data analysis problems involving large
dimension nominal variables. Moreover, what is discov-
ered in this article provides a needed starting point for the
development of statistical models and procedures to fur-
ther analyze the VAERS data. In fact, a statistical method-
ology paper (Ren and Sun: An empirical likelihood based
NROC classification procedure, in preparation) based on
Ren et al. BMCMedical Informatics and DecisionMaking          (2019) 19:101 Page 11 of 12
Fig. 8 Correlation matrix under inactivated vaccines
the results here is forthcoming. The ultimate goal is using
reliable statistical analysis to help detect and monitor the
adverse events or symptoms after vaccination in the years
to come.
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